Femtech Barometer 2025: innovation driving women’s health forward

The Femtech landscape in France

As of 2024, France is home to 170 active Femtech startups — a 21% increase year-over-year. This growth reflects a rising awareness of women’s health issues among both the general public and policymakers.

France’s political commitment to tackling issues such as endometriosis and mental health has helped create strong market opportunities for startups. At the European level, initiatives like “Choose Europe for Science” are further boosting the continent’s appeal as a hub for research and innovation.

The funding challenge

Despite growing interest, Femtech startups still face hurdles when it comes to raising capital. Many investors continue to view the sector as a niche market. However, high-profile unicorns like Flo Health (UK) and Maven (US) are helping to raise the industry’s profile and credibility with venture capitalists.

While the US, UK, and Israel remain dominant markets, France is emerging as an attractive destination thanks to a diverse investor base — even in the face of a global slowdown in fundraising in 2024.

In response to the lack of Femtech-specific investment funds, Femtech France launched the Femtech Financing Alliance, with a bold objective: mobilize €200 million by 2026 through a mix of equity and non-dilutive funding, and provide a go-to investment guide for both institutional and private backers.